Biography
Saskia de Groot completed the bachelor programme Health Policy & Management at the Erasmus University Rotterdam in 2007. In 2009, she obtained her master’s degree in Health Economics, Policy & Law. She continued her studies by enrolling in a research master programme in Health Sciences with a specialisation in Clinical Epidemiology at the Netherlands Institute for Health Sciences (2009–2011).
During her studies at the Erasmus University Rotterdam, she started working as a research assistant at the institute of Health Policy & Management. After obtaining her master's degree, she started working on a PhD project on the evaluation of clinical and economic outcomes of new therapies for metastatic renal cell carcinoma at the same institute. She finished her PhD thesis in 2016. Besides her research on conditional funding of expensive inpatient drugs, she worked on various advisory projects, including different projects for the Dutch National Health Care Institute.
Erasmus School of Health Policy & Management
- s.degroot@eshpm.eur.nl
- Location
- Burg. Oudlaan 50, Rotterdam
More information
Work
- , Valérie van Hezik-Wester, Saskia de Groot, Tim Kanters, Louis Wagner, Jacqueline Ardesch, Werner Brouwer, Isaac Corro Ramos, Saskia le Cessie, Matthijs Versteegh & Job van Exel (2024) - Effectiveness of Seizure Dogs for People With Severe Refractory Epilepsy: Results From the EPISODE Study - Neurology, 102 (6), e209178 - doi: 10.1212/wnl.0000000000209178 - [link]
- Valérie van Hezik-Wester, Saskia de Groot, Tim Kanters, Matthijs Versteegh, Louis Wagner, Jacqueline Ardesch, Werner Brouwer, Job van Exel & (2022) - Burden of illness in people with medically refractory epilepsy who suffer from daily to weekly seizures: 12-month follow-up of participants in the EPISODE study - Frontiers in Neurology, 13 - doi: 10.3389/fneur.2022.1012486 - [link]
- Philip Klein, Hedwig Blommestein, Maiwenn Al, Benedetta Pongiglione, Aleksandra Torbica & Saskia de Groot (2022) - Real-world evidence in health technology assessment of high-risk medical devices: Fit for purpose? - Health Economics (United Kingdom), 31 (S1), 10-24 - doi: 10.1002/hec.4575 - [link]
- Benedetta Pongiglione, Aleksandra Torbica, Hedwig Blommestein, Saskia De Groot, Oriana Ciani, Sarah Walker, Florian Dams, Rudolf Blankart, Meilin Mollenkamp, Sándor Kovács, Rosanna Tarricone & Mike Drummond (2021) - Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal - International Journal of Technology Assessment in Health Care, 37 (1) - doi: 10.1017/S0266462321000301 - [link]
- O Ciani, B Grigore, Hedwig Blommestein, Saskia de Groot, M Möllenkamp, S Rabbe, R Daubner-Bendes & R Taylor (2021) - Validity of Surrogate Endpoints and Their Impact on Coverage Recommendations: A Retrospective Analysis across International Health Technology Assessment Agencies - Medical Decision Making, 41 (4), 439-452 - doi: 10.1177/0272989x21994553 - [link]
- , Valérie Wester, Saskia de Groot, Matthijs Versteegh, Tim Kanters, Louis Wagner, Jacqueline Ardesch, Werner Brouwer & Job van Exel (2021) - Good Days and Bad Days: Measuring Health-Related Quality of Life in People With Epilepsy - Value in Health, 24 (10), 1470-1475 - doi: 10.1016/j.jval.2021.05.001 - [link]
- Valerie Wester, Saskia de Groot, Tim Kanters, L Wagner, J Ardesch, Isaac Corro Ramos, MJ Enders-Slegers, M de Ruiter, S le Cessie, Jeanine Los, Greg Papageorgiou, Job van Exel & Matthijs Versteegh (2020) - Evaluating the Effectiveness and Cost-Effectiveness of Seizure Dogs in Persons With Medically Refractory Epilepsy in the Netherlands: Study Protocol for a Stepped Wedge Randomized Controlled Trial (EPISODE) - Frontiers in Neurology, 11 (3) - doi: 10.3389/fneur.2020.00003 - [link]
- B Grigore, O Ciani, F Dams, C Federici, Saskia de Groot, M Möllenkamp, S Rabbe, K Shatrov, A Zemplenyi & R Taylor (2020) - Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines - Pharmacoeconomics (Print), 38, 1055-1070 - doi: 10.1007/s40273-020-00935-1 - [link]
- Gimon de Graaf, Saskia de Groot, Valerie Wester, Heleen Vellekoop, Matthijs Versteegh & M Rutten-van Molken (2019) - WAARDEBEPALING, IMPLEMENTATIE EN BEKOSTIGING VAN VOORSPELLENDE TESTEN IN NEDERLAND - [link]
- Saskia de Groot, CF (Catherine) Enters-Weijnen, PH Geelhoed-Duijvestijn & Tim Kanters (2018) - A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands - BMJ Open, 8 (3) - doi: 10.1136/bmjopen-2017-019864 - [link]
